Switzerland buys Pfizer’s COVID-19 antiviral Paxlovid

1 min read
FILE PHOTO: Pfizer and MSD oral COVID-19 pills arrive at Misericordia hospital, in Grosseto

BERLIN (Reuters) – Switzerland signed a contract to buy Pfizer’s anti-viral drug Paxlovid to treat Covid-19, it said on Friday.

The European country said it had signed a contract to buy 12,000 packages and first treatments for certain at-risk patients would start this month.

(Reporting by Kirsti Knolle, Editing by Miranda Murray)